Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P Bossi, AT Chan, L Licitra, A Trama… - Annals of …, 2021 - annalsofoncology.org
Nasopharyngeal carcinoma (NPC) is a disease with unique epidemiological features. The
distribution of the disease demonstrates a clear regional, racial and gender prevalence. In …
distribution of the disease demonstrates a clear regional, racial and gender prevalence. In …
[HTML][HTML] Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: an open-label single-arm, phase II trial
Y Hua, R You, Z Wang, P Huang, M Lin… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Toripalimab is a humanized immunoglobulin G 4 monoclonal antibody against
programmed death 1. We aimed to investigate the efficacy and safety of toripalimab in …
programmed death 1. We aimed to investigate the efficacy and safety of toripalimab in …
Baseline MRI-radiomics can predict overall survival in non-endemic EBV-related nasopharyngeal carcinoma patients
Simple Summary The prognostic performance of traditional methodologies in advanced
nasopharyngeal carcinoma does not allow to successfully stratify patients. Previous studies …
nasopharyngeal carcinoma does not allow to successfully stratify patients. Previous studies …
Proton radiation therapy for nasopharyngeal cancer patients: dosimetric and NTCP evaluation supporting clinical decision
Simple Summary Radiotherapy is the cornerstone of treatment of nasopharyngeal cancer, in
different settings with or without chemotherapy. This role has been recently strengthened by …
different settings with or without chemotherapy. This role has been recently strengthened by …
[HTML][HTML] Optimal timing of organs-at-risk-sparing adaptive radiation therapy for head-and-neck cancer under re-planning resource constraints
Background and purpose Prior work on adaptive organ-at-risk (OAR)-sparing radiation
therapy has typically reported outcomes based on fixed-number or fixed-interval re …
therapy has typically reported outcomes based on fixed-number or fixed-interval re …
Data farming to table: Combined use of a learning health system infrastructure, statistical profiling, and artificial intelligence for automating toxicity and 3-year survival …
Introduction Clinicians iteratively adjust treatment approaches to improve outcomes but to
date, automatable approaches for continuous learning of risk factors as these adjustments …
date, automatable approaches for continuous learning of risk factors as these adjustments …
The interplay between age and viral status in EBV-related nasopharyngeal and HPV-related oropharyngeal carcinoma patients
Simple Summary We analyzed 324 patients affected by loco-regionally advanced virus-and
non-virus-related head and neck cancers treated with curative intent. We aimed at assessing …
non-virus-related head and neck cancers treated with curative intent. We aimed at assessing …
Immunotherapy and modern radiotherapy technique for older patients with locally advanced head and neck cancer: A proposed paradigm by the International …
NP Nguyen, L Kim, J Thariat, BG Baumert, T Mazibuko… - Cancers, 2022 - mdpi.com
Simple Summary Immunotherapy with checkpoint inhibitors (CPI) is well tolerated in older
cancer patients due to its safety profile. In selected patients with a high program death …
cancer patients due to its safety profile. In selected patients with a high program death …
Optimal Timing of Organs-at-Risk-Sparing Adaptive Radiation Therapy for Head-and-Neck Cancer under Re-planning Resource Constraints
Abstract Background and Purpose Prior work on adaptive organ-at-risk (OAR)-sparing
radiation therapy has typically reported outcomes based on fixed-number or fixed-interval re …
radiation therapy has typically reported outcomes based on fixed-number or fixed-interval re …
Modelling Radiation-Induced Salivary Dysfunction during IMRT and Chemotherapy for Nasopharyngeal Cancer Patients
A Cavallo, NA Iacovelli, N Facchinetti, T Rancati… - Cancers, 2021 - mdpi.com
Simple Summary We built a predictive model for acute salivary dysfunction for
nasopharyngeal cancer patients receiving combined treatment. The final aim was to provide …
nasopharyngeal cancer patients receiving combined treatment. The final aim was to provide …